Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of CONvalescent Plasma in Patients With COVID-19 Treated With Mechanical Ventilation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* age at least 18 years~* hospitalization in an intensive care unit participating to the study~* medical diagnosis with SARS-CoV-2 pneumonia as defined by both:~  * extended interstitial pneumonia on CT scan or a chest X-ray, consistent with viral pneumonia, within 10 days prior to inclusion~ * Positive result of SARS-CoV-2 PCR test, or any emerging and validated diagnostic laboratory test for COVID-19, within 15 days prior to inclusion~* under mechanical ventilation administered through an endotracheal tube, for less than 5 days~* prior Clinical Frailty Scale \< 6.~* written consent of the patient, or - if impossible - of a relative acting as the legal representative, or - if impossible - of a physician from a non-participating department of the same hospital acting as an impartial witness .~Exclusion Criteria:~* Pregnancy~* Prior episode of transfusion-related side effect~* Medical decision to limit therapy~* Current participation in another trial testing a COVID-19 therapy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Convalescent Plasma (Type: EXPERIMENTAL): 2 units of plasma ( 400-500ml) from 2 different donnors duration of treatment =2 h
- Standard of care (Type: OTHER): Standard of care according the last gold standards

Based on this trial design, predict the completion outcome and termination type (if applicable).